年龄相关性黄斑变性注射频率:出行距离与出行补助的影响
研究分析旧金山退伍军人事务医疗中心眼科2010年1月1日至2019年12月31日的电子健康记录,纳入318例接受玻璃体腔注射治疗新生血管性年龄相关性黄斑变性的患者。患者距诊所中位距离为31.5英里,每增加100英里年均注射次数平均减少2.5次,但持有出行补助的患者该关联不成立,提示出行补助可减轻距离对注射依从性的影响。
要点
- 318例新生血管性年龄相关性黄斑变性患者距诊所中位距离为31.5英里(四分位距7.4-69.4英里)。
- 全部318例中,距诊所每增加100英里,年均注射次数平均减少2.5次(距离系数=-0.0025,P<0.001)。
- 有出行补助的患者中距离与年均注射次数无显著关联(距离系数=-0.0011,P=0.362)。
核心结论
- 患者距眼科诊所越远,年均注射次数越低;出行补助减轻了这一关联,提示通过援助项目改善患者依从性的机会。
研究设计与样本
- 对旧金山退伍军人事务医疗中心眼科2010年1月1日至2019年12月31日电子健康记录的分析,提取人口学数据、抗血管内皮生长因子注射史及出行补助项目入组情况。
- 采用泊松回归,以年均注射次数为结局、出行距离为主要预测因子,计算双侧P值,并评估出行补助对距离-注射关系的修饰效应。
- 共纳入318例接受玻璃体腔注射治疗新生血管性年龄相关性黄斑变性的患者。
主要发现
- 患者距诊所中位距离为31.5英里(四分位距7.4-69.4英里)。
- 全部318例患者中,距诊所每增加100英里,年均注射次数平均减少2.5次(距离系数=-0.0025,P<0.001)。
- 有出行补助的患者中,距离与年均注射次数的关联不显著(距离系数=-0.0011,P=0.362)。
临床怎么用
- 原文结论指出出行补助减轻了距离与注射次数之间的负向关联,提示可通过援助项目改善患者依从性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Although efficacious, intravitreal anti-vascular endothelial growth factor therapy regimens for neovascular age-related macular degeneration can prove difficult for patients to adhere to because of high cost and burden of transportation. METHODS: Analysis of electronic health record data from the San Francisco Veterans Administration Medical Center eye clinic (January 1, 2010 to December 31, 2019) was performed, extracting demographic data, anti-vascular endothelial growth factor injection history, and enrollment in the SFVA travel benefit program. Two-tailed P -values were calculated for Poisson regression examining average number of injections per year as the outcome and distance traveled as the primary predictor. Travel benefit was evaluated as a modifying effect on the distance-injection relationship. RESULTS: Three hundred and eighteen patients who received intravitreal injection for treatment of neovascular age-related macular degeneration were included in the analysis. Median (interquartile range) distance to clinic was 31.5 miles (7.4-69.4 miles). Driving distance in miles was inversely associated with average number of injections per year. Among all 318 patients, for every additional 100 miles a patient lived from our clinic, the patient received on average 2.5 fewer injections per year ( distance = -0.0025, P < 0.001), but this was not the case for patients with travel benefits ( distance = -0.0011, P = 0.362). CONCLUSION: The greater the distance from a patient's eye clinic, the lower the average number of injections per year. However, travel benefits mitigated this relationship, highlighting opportunities for improving patient's adherence through assistance programs.
引用
- Meer EA, Targ S, Zhang N, et al. AGE-RELATED MACULAR DEGENERATION INJECTION FREQUENCY: Effects of Distance Traveled and Travel Support. Retina. 2024. PMID: 37756667. doi:10.1097/IAE.0000000000003947
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。